Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Abametapir - Hatchtech

X
Drug Profile

Abametapir - Hatchtech

Alternative Names: BRN-0123183; DeOvo Lotion; DFD-11; HA-44; Ha44; Ha44 Gel; Xeglyze Lotion

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hatchtech
  • Developer Dr Reddys Laboratories; Hatchtech
  • Class Antiparasitics; Heterocyclic compounds; Pyridines; Small molecules
  • Mechanism of Action Chelating agents; Metalloprotease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Pediculosis

Most Recent Events

  • 27 Jul 2020 Registered for Pediculosis (In adolescents, In children, In infants, In adults) in USA (Topical)
  • 18 Jun 2020 FDA assigns PDUFA action date of 12/08/2020 for Abametapir for Pediculosis (Dr Reddy's Laboratories website, June 2020)
  • 31 Mar 2019 Abametapir is still in preregistration phase for Pediculosis in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top